Great news, we needed some. The Heart/LVAD is ONE of our Crown Jewels. The data already in and now AA. Could a soon to be announced partnership on the back of this announcement, be the solution to the “cashflow cliff edge “ we can all see looming? Or will the potency assay resolution and approval for SRGVHD beat it? The dilution and collapse of the share price has been painful for many of us. The data has always been there since I invested. Perhaps finally we will this year see clarity in the time horizon for that data to finally come to the US market by an approval or a JV.
And Arsenal are top of the league.
regards
Yelrom
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-42
-
- There are more pages in this discussion • 508 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.045(4.00%) |
Mkt cap ! $1.335B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.18 | $1.13 | $4.980M | 4.315M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 73090 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 27903 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |